Technology: Neurological Disorders
Headquarters: Ann Arbor, Michigan, United States
Funding Status: M&A
Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Investors Number: 12
Estimated Revenue: Less than $1M
Total Funding: $106M
Industry: Gene Therapy